tiprankstipranks
Advertisement
Advertisement
Immutep Faces Nasdaq Bid-Price Deficiency but Retains Listings as It Seeks Compliance
PremiumCompany AnnouncementsImmutep Faces Nasdaq Bid-Price Deficiency but Retains Listings as It Seeks Compliance
24d ago
Immutep Halts Key Lung Cancer Trial but Pipeline Advances on Solid Cash Base
Premium
Company Announcements
Immutep Halts Key Lung Cancer Trial but Pipeline Advances on Solid Cash Base
24d ago
Immutep to Present New Eftilagimod Alfa Data at ASCO 2026
Premium
Company Announcements
Immutep to Present New Eftilagimod Alfa Data at ASCO 2026
1M ago
Insignia Financial Ceases to Be Substantial Holder in Immutep
PremiumCompany AnnouncementsInsignia Financial Ceases to Be Substantial Holder in Immutep
2M ago
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
Premium
Company Announcements
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
2M ago
UBS Group Ceases to Be Substantial Shareholder in Immutep
Premium
Company Announcements
UBS Group Ceases to Be Substantial Shareholder in Immutep
2M ago
Immutep downgraded to Market Perform from Outperform at Citizens
PremiumThe FlyImmutep downgraded to Market Perform from Outperform at Citizens
2M ago
Immutep Trading Resumes on ASX After Key Phase III Trial Update
Premium
Company Announcements
Immutep Trading Resumes on ASX After Key Phase III Trial Update
2M ago
Immutep Halts Pivotal Lung Cancer Trial After Futility Review
Premium
Company Announcements
Immutep Halts Pivotal Lung Cancer Trial After Futility Review
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100